Orthofix Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orthofix Medical generated cash of -$45,753,000, which is less than the previous year. Cash used in financing activities reached the amount of $65,322,000 last year. Net change in cash is therefore -$12,943,000.
Cash Flow
| 2014 | 50.95M | -19.95M | -19.99M |
|---|---|---|---|
| 2015 | 43.22M | -38.34M | 25.11M |
| 2016 | 44.70M | -21.94M | -46.11M |
| 2017 | 53.34M | -16.47M | 3.53M |
| 2018 | 49.91M | -60.99M | 2.99M |
| 2019 | 32.03M | -22.92M | -10.68M |
| 2020 | 74.27M | -52.33M | 3.24M |
| 2021 | 18.47M | -23.01M | -3.62M |
| 2022 | -11.53M | -24.53M | -78K |
| 2023 | -45.75M | -33.13M | 65.32M |
OFIX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 50.7M | 87.84M | 96.82M | 70.40M | 72.18M | 81.15M | 39.57M | 63.66M | 36.81M | 28.92M |
Operating activities | ||||||||||
Net income | -151.39M | -19.74M | -38.37M | 2.51M | -28.46M | 13.81M | 6.22M | 3.05M | -2.80M | -8.53M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 60.59M | 32.07M | 33.09M | 34.27M | 24.69M | 18.65M | 20.12M | 20.84M | 20.92M | 22.87M |
Stock-based compensation expense | 35.70M | 18.44M | 15.43M | 16.20M | 21.54M | 0 | 12.55M | 15.96M | 7.21M | 5.72M |
| Deferred income tax benefit | 35.70M | 18.44M | 15.43M | 16.20M | 21.54M | 0 | 12.55M | 15.96M | 7.21M | 5.72M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -6.73M | -7.04M | 13.28M | -11.03M | -3.70M | -6.56M | 392K | -1.54M | 6.13M |
Inventories | 0 | -18.13M | 619K | -873K | -5.71M | 9.69M | -15.64M | -5.28M | 3.13M | 8.10M |
Accounts payable | 8.64M | 2.28M | 4.25M | 2.53M | 2.13M | -170K | 2.32M | -1.77M | 3.01M | -6.45M |
Cash generated by operating activities | -45.75M | -11.53M | 18.47M | 74.27M | 32.03M | 49.91M | 53.34M | 44.70M | 43.22M | 50.95M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | -2.17M | -10M | 0 | 0 | 0 | -3.61M | -15.25M | -1.45M |
Investments In Property Plant And Equipment | -60.25M | -23.16M | -19.59M | -17.09M | -20.52M | -15.25M | -16.94M | -18.33M | -27.89M | -18.52M |
Acquisitions Net | 29.41M | -1.5M | 0 | -18M | 0 | -44.29M | 0 | 0 | 0 | 18.52M |
Cash generated by investing activities | -33.13M | -24.53M | -23.01M | -52.33M | -22.92M | -60.99M | -16.47M | -21.94M | -38.34M | -19.95M |
Financing activities | ||||||||||
Common Stock Issued | 5.12M | 4.33M | 8.82M | 7.59M | 11.55M | 7.1M | 7.78M | 19.72M | 5.25M | 10.46M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -2.55M | -2.49M | 0 | -3.42M | 0 | -63.42M | -11.57M | -612K |
Repayments of term debt | 67.94M | -2.59M | -537K | -100.32M | -365K | 0 | 0 | 0 | 0 | -20M |
Cash used in financing activities | 65.32M | -78K | -3.62M | 3.24M | -10.68M | 2.99M | 3.53M | -46.11M | 25.11M | -19.99M |
Net Change In Cash | -12.94M | -37.14M | -8.97M | 26.41M | -1.78M | -8.96M | 41.58M | -24.09M | 26.84M | 7.89M |
Cash at end of period | 37.75M | 50.7M | 87.84M | 96.82M | 70.40M | 72.18M | 81.15M | 39.57M | 63.66M | 36.81M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |